Recombinant Human RXRg Protein，His

RXRg, or Retinoid X Receptor gamma, is a member of the nuclear receptor superfamily that plays a crucial role in various biological processes, including metabolism, cell differentiation, and immune response. Its function is significantly influenced by its ability to form heterodimers with other nuclear receptors, which modulates gene expression in response to retinoids and fatty acids. Dysfunction or aberrant signaling of RXRg has been implicated in several pathological conditions, such as obesity, diabetes, and certain types of cancer. Research on RXRg has garnered interest due to its potential as a therapeutic target, particularly in the context of metabolic disorders and cancer, where modulation of its activity could yield beneficial effects. The recombinant expression of RXRg in various systems enables detailed structural and functional studies, facilitating the discovery of small molecules that can selectively modulate its activity. Recent advances in protein engineering and structural biology have provided insights into the ligand-binding domain and the conformational changes associated with RXRg activation. Understanding the precise mechanisms of RXRg action and its interactions at the molecular level is critical for the development of innovative therapeutic strategies aimed at harnessing its function for disease intervention. As such, RXRg serves as a pertinent focus of research within the fields of pharmacology and molecular biology, underscoring its relevance in understanding complex regulatory networks.